Annie Otto‐Bruc

755 total citations
16 papers, 632 citations indexed

About

Annie Otto‐Bruc is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cell Biology. According to data from OpenAlex, Annie Otto‐Bruc has authored 16 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Cell Biology. Recurrent topics in Annie Otto‐Bruc's work include Retinal Development and Disorders (7 papers), Receptor Mechanisms and Signaling (5 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Annie Otto‐Bruc is often cited by papers focused on Retinal Development and Disorders (7 papers), Receptor Mechanisms and Signaling (5 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Annie Otto‐Bruc collaborates with scholars based in France, United States and Germany. Annie Otto‐Bruc's co-authors include Pierre Teilhard de Chardin, Bruno Antonny, Marc Chabre, Wolfgang Baehr, Krzysztof Palczewski, T. Minh Vuong, Eva Faurobert, Robert N. Fariss, Karine Robbe-Sermesant and Irina Surgucheva and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Annie Otto‐Bruc

16 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annie Otto‐Bruc France 11 553 301 113 72 49 16 632
Iswari Subbaraya United States 10 789 1.4× 517 1.7× 131 1.2× 222 3.1× 37 0.8× 11 848
Rehwa H. Lee United States 14 699 1.3× 370 1.2× 69 0.6× 98 1.4× 10 0.2× 17 814
Alexander Pulvermüller Germany 15 928 1.7× 603 2.0× 167 1.5× 38 0.5× 16 0.3× 20 976
Alecia K. Gross United States 16 722 1.3× 395 1.3× 135 1.2× 170 2.4× 14 0.3× 36 835
Nicolas Genoud Switzerland 8 561 1.0× 310 1.0× 156 1.4× 12 0.2× 19 0.4× 10 740
D. Lucille Bredberg United States 10 705 1.3× 223 0.7× 114 1.0× 242 3.4× 14 0.3× 11 732
Somes Sanyal Netherlands 12 553 1.0× 232 0.8× 122 1.1× 149 2.1× 9 0.2× 18 607
Robert St. Jules United States 10 354 0.6× 237 0.8× 72 0.6× 26 0.4× 7 0.1× 16 434
Xi-Qin Ding United States 13 412 0.7× 239 0.8× 72 0.6× 123 1.7× 10 0.2× 25 470

Countries citing papers authored by Annie Otto‐Bruc

Since Specialization
Citations

This map shows the geographic impact of Annie Otto‐Bruc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Otto‐Bruc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Otto‐Bruc more than expected).

Fields of papers citing papers by Annie Otto‐Bruc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Otto‐Bruc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Otto‐Bruc. The network helps show where Annie Otto‐Bruc may publish in the future.

Co-authorship network of co-authors of Annie Otto‐Bruc

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Otto‐Bruc. A scholar is included among the top collaborators of Annie Otto‐Bruc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Otto‐Bruc. Annie Otto‐Bruc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Burbank, Matthew J., Predrag Kukić, Gladys Ouédraogo, et al.. (2024). In vitro pharmacologic profiling aids systemic toxicity assessment of chemicals. Toxicology and Applied Pharmacology. 492. 117131–117131. 2 indexed citations
2.
VanderMolen, Karen M., Jorge M. Naciff, Kevin J. Kennedy, et al.. (2020). Incorporation of in vitro techniques for botanicals dietary supplement safety assessment – Towards evaluation of developmental and reproductive toxicity (DART). Food and Chemical Toxicology. 144. 111539–111539. 3 indexed citations
3.
Jenkinson, Stephen, et al.. (2020). Translation of in vitro cannabinoid 1 receptor agonist activity to in vivo pharmacodynamic endpoints. Journal of Pharmacological and Toxicological Methods. 104. 106899–106899. 1 indexed citations
4.
Robbe-Sermesant, Karine, Annie Otto‐Bruc, Pierre Teilhard de Chardin, & Bruno Antonny. (2003). Dissociation of GDP Dissociation Inhibitor and Membrane Translocation Are Required for Efficient Activation of Rac by the Dbl Homology-Pleckstrin Homology Region of Tiam. Journal of Biological Chemistry. 278(7). 4756–4762. 72 indexed citations
5.
Otto‐Bruc, Annie, J. Preston Van Hooser, & Robert N. Fariss. (2000). [16] Use of α-toxin-permeabilized photoreceptors in in vitro phototransduction studies. Methods in enzymology on CD-ROM/Methods in enzymology. 316. 269–278. 1 indexed citations
6.
Sokal, Izabela, Annie Otto‐Bruc, Irina Surgucheva, et al.. (1999). Conformational Changes in Guanylyl Cyclase-activating Protein 1 (GCAP1) and Its Tryptophan Mutants as a Function of Calcium Concentration. Journal of Biological Chemistry. 274(28). 19829–19837. 46 indexed citations
7.
Li, Ning, Robert N. Fariss, Annie Otto‐Bruc, et al.. (1998). Guanylate‐cyclase‐inhibitory protein is a frog retinal Ca2+‐binding protein related to mammalian guanylate‐cyclase‐activating proteins. European Journal of Biochemistry. 252(3). 591–599. 41 indexed citations
8.
Otto‐Bruc, Annie, Robert N. Fariss, J. Preston Van Hooser, & Krzysztof Palczewski. (1998). Phosphorylation of photolyzed rhodopsin is calcium-insensitive in retina permeabilized by α-toxin. Proceedings of the National Academy of Sciences. 95(25). 15014–15019. 34 indexed citations
9.
Moon, Cheil, et al.. (1998). Calcium-Sensitive Particulate Guanylyl Cyclase as a Modulator of cAMP in Olfactory Receptor Neurons. Journal of Neuroscience. 18(9). 3195–3205. 56 indexed citations
10.
Otto‐Bruc, Annie, Janina Buczyłko, Irina Surgucheva, et al.. (1997). Functional Reconstitution of Photoreceptor Guanylate Cyclase with Native and Mutant Forms of Guanylate Cyclase-Activating Protein 1. Biochemistry. 36(14). 4295–4302. 71 indexed citations
11.
Otto‐Bruc, Annie, Robert N. Fariss, Françoise Haeseleer, et al.. (1997). Localization of guanylate cyclase-activating protein 2 in mammalian retinas. Proceedings of the National Academy of Sciences. 94(9). 4727–4732. 73 indexed citations
12.
Otto‐Bruc, Annie, Bruno Antonny, & T. Minh Vuong. (1994). Modulation of the GTPase Activity of Transducin. Kinetic Studies of Reconstituted Systems. Biochemistry. 33(51). 15215–15222. 19 indexed citations
13.
Otto‐Bruc, Annie, T. Minh Vuong, & Bruno Antonny. (1994). GTP‐dependent binding of Gi, Go and Gs to the γ‐subunit of the effector of Gt. FEBS Letters. 343(3). 183–187. 5 indexed citations
14.
Otto‐Bruc, Annie, Bruno Antonny, T. Minh Vuong, Pierre Teilhard de Chardin, & Marc Chabre. (1993). Interaction between the retinal cyclic GMP phosphodiesterase inhibitor and transducin. Kinetics and affinity studies. Biochemistry. 32(33). 8636–8645. 66 indexed citations
15.
Faurobert, Eva, Annie Otto‐Bruc, Pierre Teilhard de Chardin, & Marc Chabre. (1993). Tryptophan W207 in transducin T alpha is the fluorescence sensor of the G protein activation switch and is involved in the effector binding.. The EMBO Journal. 12(11). 4191–4198. 95 indexed citations
16.
Antonny, Bruno, Annie Otto‐Bruc, Marc Chabre, & T. Minh Vuong. (1993). GTP hydrolysis by purified .alpha.-subunit of transducin and its complex with the cyclic GMP phosphodiesterase inhibitor. Biochemistry. 32(33). 8646–8653. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026